Skip to main content
Equibles

MetLife Investment Management, LLC

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1529735 Whippany, NJ
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$145,960
+$76,358 QoQ
Shares Held
30,095
+31.0% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 114 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. ZNTL ranks #214 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in ZNTL

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $145,960 30,095
2024-12-31 $69,602 22,971
2024-09-30 $125,451 34,090
2024-06-30 $139,428 34,090
2024-03-31 $483,863 30,702
2023-12-31 $465,135 30,702
2023-09-30 $615,882 30,702
2023-06-30 $720,596 25,544
2023-03-31 $428,899 24,936
2022-12-31 $502,211 24,936
2022-09-30 $540,113 24,936
2022-06-30 $552,586 19,665
2022-03-31 $907,343 19,665
2021-12-31 $1,052,935 12,526
2021-09-30 $834,732 12,526
2021-06-30 $630,313 11,848
2021-03-31 $514,084 11,848
2020-12-31 $615,385 11,848
2020-09-30 $165,967 5,077
2020-06-30 $487,595 10,154